§ Funding Round
Series C funding round for Amolyt Pharma raising $140M in January 2023
Series C funding round for Amolyt Pharma raising $140M in January 2023
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
Domain Associates | — | — |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | vincent brichard | |
| Organization | — | |
| Organization | — | |
Credit Agricole Creation | — | — |
| Organization | — | |
toby sykesLEAD | Angel | toby sykes |
LSP | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Relyens Innovation Sant | — | — |
| Organization | — | |
Cédric MoreauLEAD | — | — |
| Organization | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$305.5M
Top Valuation
-
Amolyt Pharma raised $140M in a Series C round.
The round was announced on 01/01/23.
The round was led by toby sykes, Cédric Moreau.
